Did you know that your DNA can provide insights that can help with treatment planning? In this episode of the DBSA podcast, we talk to Dr. Mark Pollack, Chief Medical Officer and Vice President of Clinical Affairs of Myriad Neuroscience, about what pharmacogenetic testing is, how the testing works, and what benefits it can offer peers. We also talk to Dennis L., a peer who details his journey with Major Depression and how pharmacogenetic testing helped improve his treatment plan.
What is pharmacogenetic testing? This test uses a small sample of your DNA, usually obtained by swabbing the inside of your cheek, to learn how your genetic makeup can affect your response to medication. Doctors use this information as a tool to help make prescription decisions. Along with PGx test results, your age, gender, other medical conditions, and any other drugs you take may also be factors in your doctor’s recommendations about possible treatments.
Footnotes:
Learn more about PGx https://www.dbsalliance.org/wellness/treatment-options/what-is-pharmacogenetic-testing/
Learn about DBSA Peer Specialist Program
https://www.dbsalliance.org/get-involved/training/
DBSA would like to thank Myriad for supporting this episode.
